19.11.2020, 11:47

Vietnam sole Asian country in UK global healthcare initiative

Vietnam sole Asian country in UK global healthcare initiative

The Partnership for Global Health System Sustainability and Resilience (PHSSR), founded by the WEF, the London School of Economics and British biopharmaceutical firm AstraZeneca, aims to help health systems foresee, prevent, and adapt to global health challenges by initiating broad, multi-sector efforts, according to a press release issued by the U.K. embassy in Vietnam.

The partnership was launched in Hanoi on Tuesday night, it added.

In its pilot phase, expected to run until January next year, the PHSSR would be implemented in eight countries, the other seven being France, Germany, Italy, Poland, Russia, Spain and the U.K.

Vietnam was chosen for its “unique health system experiences and expertise, including its effective Covid-19 response,” the release said.

The PHSSR Vietnam team, led by Tran Thi Mai Oanh, director of the Health Strategy and Policy Institute, will conduct a review of the country’s health system sustainability and resilience and identify ways to strengthen them.

It will answer key questions that determine health system resilience and sustainability, like how it is governed and funded and how it harnesses medicine and technology.

Vietnam could be among the first countries to pioneer some solutions identified through the partnership by the end of this year, experts said at the launch.

“Difficult though it might be to imagine now, the day will arrive when Covid-19 will no longer be the world’s principal health concern. Instead of focusing exclusively on bringing the pandemic under control, we need to build systems that are capable of responding to routine as well as unexpected challenges.

“We want to do this by breaking down the traditional barriers between academia, business and the public sector and creating a platform to disseminate breakthrough insights, and enable health systems to act upon them.”

Vietnam has had 1,300 Covid-19 cases so far, 138 still active. Thirty five have died of the disease, many of them elderly patients with underlying conditions like diabetes and kidney failure.